A new study in Africa has found that a one-time dose of an experimental drug protects adults against malaria for at least six months. In 2020, malaria killed more than 620,000 people and sickened 241 million, mostly children under 5.

STS Digital Named Digital Asset Provider of the Year by FOW

STS Digital Launches Smart Bitcoin, Expanding Its Structured Products Offering with Quantitative Investment Strategies

STS Digital Launches Cross-Asset Portfolio Margin for Institutional Digital Asset Trading

Papa Johns teams up with Disney and Pixar for Toy Story 5

Silver tumbles as COMEX margins rise and volatility spikes

Browsing: Featured News

Innovative experimental malaria drug based on antibodies discovered

DR Congo Ebola count reaches 8,067 cases across 7 provinces

India-US trade pact talks return at G20 meeting in Milwaukee

Suleiman Khan alleges tyranny before PTI Islamabad march

UAE Zambia leaders discuss trade investment and CEPA

flydubai showcases growing Syria network at Damascus show

Sheikh Saif meets Interpol president on margins of world event

Mansour bin Zayed Turkish Foreign Minister discuss strategic partnership

Abu Dhabi rises to 33rd place JLL global transparency index